Nav: Home

Smarter drug release thanks to control over encapsulation

March 19, 2019

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs. This gives more control over the slow and steady release of drugs in patients. Moreover, designing encapsulations for new drugs will now require far less experimentation which makes for faster and cheaper drug development. The researchers believe this work will have a significant impact on the biomedical field and designing future drugs.

Many drugs are hydrophobic--they do not dissolve well in water--which makes drug delivery in patients problematic. One possible solution is to encapsulate the drugs in small packages that are hydrophobic (water-repellent) on the inside and hydrophilic (water-soluble) on the outside. The drugs will accumulate in the inside of these packages and the transportation of the drug throughout the patient's body becomes much easier. The packages often consist of associated surfactants, which are pharma-approved. When dissolved in water, a physiological solution, or blood, these molecules orient their hydrophobic part towards the inside core (with affinity for the insoluble drugs) and their hydrophilic side towards the outside, forming a spherical 'package', called a micelle.

The whereabouts in a micelle

Transporting drugs throughout the body in this way has been possible for decades, but only now researchers understand which factors exactly dictate where the drugs inside the micelle gather. This spatial distribution can dramatically affect the release rate of the drugs inside a patient. Some drugs concentrate at the center of the hydrophobic core of the micelle and release slowly, which is desirable for the drug uptake of a patient. Other drugs gather at the core-shell interface of the micelle and release typically fast. Therefore, controlling the location of the drugs in the micelle encapsulation controls the release rate of the drugs.

Using a dye to track drug

To investigate where insoluble drugs gather, the researchers used Nile Red, a dye molecule that resembles the size and solubility of typical drugs. The dye has a very clever property: not only does it absorb a specific color of light, but also that color depends on its environment. If the dye is dissolved in pure water, it absorbs light of a different color than if is there is also some alcohol dissolved in the water. Changing the water/alcohol ratio is a clever way to simulate a good solvent or a poor solvent for the dye. This is analogous to working with a water soluble drug or an insoluble drug. By measuring the light absorption, the researchers could determine how much dye gathered at the core of the micelle and how much at the core-shell interface.

Experiments combined with computer simulations

To confirm their findings, the researchers did computer simulations to determine the locations of the dissolved drugs and the shape of the block copolymer micelle. The computations reveal the arrangement of the components inside and outside the micelle, enabling to assess the preferred regions of the drug.

From the experiments and computations it was concluded that the preferred region of the drug inside the block copolymer micelles is mostly determined by the concentration and the solubility of the drug molecules in the surrounding medium (water/physiological medium/blood). If the concentration of the drug is below the water solubility of the solvent the drug molecules gather at the core-shell interface of the micelle, while if the concentration is above the solubility they gather in the core.

Fewer trail-and-error experimentation

Today's drug encapsulation research is dominated by trail-and-error experimentation. The results reported in this study enable easier and cheaper development of smart drugs. This will help reduce side effects associated with therapy and facilitate the creation of personalized therapeutic treatments where the release of the drug is adjusted to the individual needs of the patient.
Article reference

"Controlling the spatial distribution of solubilized compounds within copolymer micelles", Alessandro Ianiro, Álvaro González García, Stefan Wijker, Joseph P. Patterson, A. Catarina C. Esteves, and Remco Tuinier Langmuir Just Accepted Manuscript DOI:10.1021/acs.langmuir.9b00180

Eindhoven University of Technology

Related Drugs Articles:

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.
A homing beacon for chemotherapy drugs
Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.
Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.
Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.
Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.
New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.
New TB drugs possible with understanding of old antibiotic
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and the Francis Crick Institute.
Versatile cancer drugs
Medications which block enzymes belonging to the kinase family, are among the most effective pharmaceuticals for targeted cancer therapies.
When HIV drugs don't cooperate
Researchers at Thomas Jefferson University studying combinations of drugs against HIV have discovered why some drugs sometimes act synergistically but sometimes do not.
'Accelerated approval' drugs: How well are they studied?
In a recent study published in JAMA, researchers at Brigham and Women's Hospital and the London School of Economics and Political Science examined the pre-approval and post-approval clinical trials of drugs granted FDA Accelerated Approval between 2009 and 2013.
More Drugs News and Drugs Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab